Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: Preliminary Results of the Sisonke 2 Study

Glenda E Gray, Shirley Collie, Nigel Garrett, View ORCID ProfileAmeena Goga, Jared Champion, Matthew Zylstra, Tarylee Reddy, Nonhlanhla Yende, Ishen Seocharan, Azwi Takalani, Ian Sanne, Fatima Mayat, Jacky Odhiambo, Lesley Bamford, Harry Moultrie, Lara Fairall, View ORCID ProfileLinda-Gail Bekker on behalf of the Sisonke Study Team
doi: https://doi.org/10.1101/2021.12.28.21268436
Glenda E Gray
1South African Medical Research Council;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shirley Collie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nigel Garrett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ameena Goga
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ameena Goga
Jared Champion
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Zylstra
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tarylee Reddy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nonhlanhla Yende
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ishen Seocharan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Azwi Takalani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian Sanne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fatima Mayat
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacky Odhiambo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lesley Bamford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harry Moultrie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lara Fairall
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda-Gail Bekker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Linda-Gail Bekker
  • For correspondence: Linda-gail.bekker@hiv-research.org.za
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Following the results of the ENSEMBLE 2 study, which demonstrated improved vaccine efficacy of a two-dose regimen of Ad26.COV.2 vaccine given 2 months apart, we expanded the Sisonke study which had provided single dose Ad26.COV.2 vaccine to almost 500 000 health care workers (HCW) in South Africa to include a booster dose of the Ad26.COV.2. Sisonke 2 enrolled 227 310 HCW from the 8 November to the 17 December 2021. Enrolment commenced before the onset of the Omicron driven fourth wave in South Africa affording us an opportunity to evaluate early VE in preventing hospital admissions of a homologous boost of the Ad26.COV.2 vaccine given 6-9 months after the initial vaccination in HCW.

We estimated vaccine effectiveness (VE) of the Ad26.COV2.S vaccine booster in 69 092 HCW as compared to unvaccinated individuals enrolled in the same managed care organization using a test negative design. We compared VE against COVID19 admission for omicron during the period 15 November to 20 December 2021. After adjusting for confounders, we observed that VE for hospitalisation increased over time since booster dose, from 63% (95%CI 31-81%); to 84% (95% CI 67-92%) and then 85% (95% CI: 54-95%), 0-13 days, 14-27 days, and 1-2 months post-boost.

We provide the first evidence of the effectiveness of a homologous Ad26.COV.2 vaccine boost given 6-9 months after the initial single vaccination series during a period of omicron variant circulation. This data is important given the increased reliance on the Ad26.COV.2 vaccine in Africa.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT05148845

Funding Statement

Funding was provided by the National Treasury of South Africa, the National Department of Health, Solidarity Response Fund NPC, The Michael & Susan Dell Foundation, The Elma Vaccines and Immunization Foundation Grant number 21 V0001, and the Bill & Melinda Gates Foundation grant number INV 030342.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Protocol was reviewed and approved by the South African Health and Products Regulatory Agency, and all health research ethics committees associated with Sisonke clinical research sites. Approvals and data sharing agreements enabled research team access to anonymized unvaccinated datasets post matching. A protocol safety team met each week to review all safety events, break-through infections and deaths. The Protocol Safety Committee provided independent oversight of the study. The trial was registered at South African National Clinical Trial Registry; clin.gov and the Pan African Clinical Trials Registry.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 29, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: Preliminary Results of the Sisonke 2 Study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: Preliminary Results of the Sisonke 2 Study
Glenda E Gray, Shirley Collie, Nigel Garrett, Ameena Goga, Jared Champion, Matthew Zylstra, Tarylee Reddy, Nonhlanhla Yende, Ishen Seocharan, Azwi Takalani, Ian Sanne, Fatima Mayat, Jacky Odhiambo, Lesley Bamford, Harry Moultrie, Lara Fairall, Linda-Gail Bekker
medRxiv 2021.12.28.21268436; doi: https://doi.org/10.1101/2021.12.28.21268436
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: Preliminary Results of the Sisonke 2 Study
Glenda E Gray, Shirley Collie, Nigel Garrett, Ameena Goga, Jared Champion, Matthew Zylstra, Tarylee Reddy, Nonhlanhla Yende, Ishen Seocharan, Azwi Takalani, Ian Sanne, Fatima Mayat, Jacky Odhiambo, Lesley Bamford, Harry Moultrie, Lara Fairall, Linda-Gail Bekker
medRxiv 2021.12.28.21268436; doi: https://doi.org/10.1101/2021.12.28.21268436

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (506)
  • Anesthesia (110)
  • Cardiovascular Medicine (1245)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (534)
  • Epidemiology (10032)
  • Forensic Medicine (5)
  • Gastroenterology (500)
  • Genetic and Genomic Medicine (2467)
  • Geriatric Medicine (238)
  • Health Economics (480)
  • Health Informatics (1647)
  • Health Policy (754)
  • Health Systems and Quality Improvement (637)
  • Hematology (250)
  • HIV/AIDS (536)
  • Infectious Diseases (except HIV/AIDS) (11872)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (253)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2290)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (537)
  • Oncology (1249)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (325)
  • Pediatrics (734)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2281)
  • Public and Global Health (4844)
  • Radiology and Imaging (843)
  • Rehabilitation Medicine and Physical Therapy (492)
  • Respiratory Medicine (652)
  • Rheumatology (286)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (227)
  • Surgery (269)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)